Troponin in early presenters to rule out myocardial infarction

Matthew T H Lowry,Dimitrios Doudesis,Jasper Boeddinghaus,Dorien M Kimenai,Anda Bularga,Caelan Taggart,Ryan Wereski,Amy V Ferry,Stacey D Stewart,Christopher Tuck,Luca Koechlin,Thomas Nestelberger,Pedro Lopez-Ayala,Gabrielle Huré,Kuan Ken Lee,Andrew R Chapman,David E Newby,Atul Anand,Paul O Collinson,Christian Mueller,Nicholas L Mills,Nicholas L Mills,Fiona E Strachan,Christopher Tuck,Atul Anand,Stephanie Barker,Jennifer Blades,Jasper Boeddinghaus,Anda Bularga,Andrew R Chapman,Dimitrios Doudesis,Amy V Ferry,Takeshi Fujisawa,Konstantin Georgiev,Dorien M Kimenai,Kuan Ken Lee,Ziwen Li,Matthew TH Lowry,Lynn McKinlay,Michael McDermott,Jean McPherson,Filip Mendusic,Nicholas L Mills,Andrew Sorbie,Grace Souter,Stacey D Schulberg,Caelan Taggart,Christopher Tuck,Daniel Perez-Vicencio,Yiqing Wang,Ryan Wereski,Kelly Williams,Nicholas L Mills,David E Newby,Keith AA Fox,Colin Berry,Simon Walker,Christopher J Weir,Ian Ford,Nicholas L Mills,David E Newby,Alasdair Gray,Keith AA Fox,Colin Berry,Simon Walker,Paul O Collinson,Fred S Apple,Alan Reid,Anne Cruikshank,Iain Findlay,Shannon Amoils,David A McAllister,Donogh Maguire,Jennifer Stevens,John Norrie,Christopher J Weir,Anoop SV Shah,Atul Anand,Andrew R Chapman,Kuan Ken Lee,Jack PM Andrews,Philip D Adamson,Alastair Moss,Mohamed S Anwar,John Hung,Nicholas L Mills,Simon Walker,Jonathan Malo,Alan Reid,Anne Cruikshank,Paul O Collinson,Colin M Fischbacher,Bernard L Croal,Stephen J Leslie,Catriona Keerie,Richard A Parker,Allan Walker,Ronnie Harkess,Christopher Tuck,Tony Wackett,Christopher Weir,Roma Armstrong,Laura Stirling,Claire MacDonald,Imran Sadat,Frank Finlay,Kathy Harrison,Atul Anand,Pamela Linksted,Stephen Lavenberg,High-STEACS Investigators

DOI: https://doi.org/10.1093/eurheartj/ehad376

IF: 39.3

2023-06-26

European Heart Journal

Abstract:Aims Whether a single cardiac troponin measurement can safely rule out myocardial infarction in patients presenting within a few hours of symptom onset is uncertain. The study aim was to assess the performance of troponin in early presenters. Methods and results In patients with possible myocardial infarction, the diagnostic performance of a single measurement of high-sensitivity cardiac troponin I at presentation was evaluated and externally validated in those tested ≤3, 4–12, and >12 h from symptom onset. The limit-of-detection (2 ng/L), rule-out (5 ng/L), and sex-specific 99th centile (16 ng/L in women; 34 ng/L in men) thresholds were compared. In 41 103 consecutive patients [60 (17) years, 46% women], 12 595 (31%) presented within 3 h, and 3728 (9%) had myocardial infarction. In those presenting ≤3 h, a threshold of 2 ng/L had greater sensitivity and negative predictive value [99.4% (95% confidence interval 99.2%–99.5%) and 99.7% (99.6%–99.8%)] compared with 5 ng/L [96.5% (96.2%–96.8%) and 99.3% (99.1%–99.4%)]. In those presenting ≥3 h, the sensitivity and negative predictive value were similar for both thresholds. The sensitivity of the 99th centile was low in early and late presenters at 71.4% (70.6%–72.2%) and 92.5% (92.0%–93.0%), respectively. Findings were consistent in an external validation cohort of 7088 patients. Conclusion In early presenters, a single measurement of high-sensitivity cardiac troponin I below the limit of detection may facilitate the safe rule out of myocardial infarction. The 99th centile should not be used to rule out myocardial infarction at presentation even in those presenting later following symptom onset.

cardiac & cardiovascular systems